-
2 months ago | 
patientcareonline.com | Mona Shahriari |Grace Halsey
The well-known limitations of topical corticosteroids for treatment of atopic dermatitis (AD), or eczema, include skin atrophy, skin barrier disruption, rebound flares, and tachyphylaxis, the last of which may require an increase in potency or switching to an alternative treatment. While the topical steroids can be effective for short-term management of acute eczema flares, they may not provide adequate long-term control for the chronic relapsing skin disease.
-
2 months ago | 
patientcareonline.com | Mona Shahriari |Grace Halsey
Atopic dermatitis appears to be more common now than it was 10 or 15 years ago, according to Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, CT. One of the primary reasons, she explained in a recent interview with Patient Care,® is that "how we define [the condition] is starting to shift.
-
2 months ago | 
patientcareonline.com | Mona Shahriari |Grace Halsey
Atopic dermatitis (AD) is one of the most common chronic skin conditions, affecting millions of all ages. With about 80% of patients managed initially in primary care and the limited access in many places to dermatologists, the role of the frontline clinicians in diagnosing and initiating treatment for AD is expanding.
-
2 months ago | 
patientcareonline.com | Mona Shahriari |Grace Halsey
"The bottom line is, topical therapy is still a cornerstone in treating atopic dermatitis, whether we're treating mild, moderate or severe disease," Mona Shahriari, MD, emphasized during a recent interview with Patient Care.® Even when one of her patients is on a systemic biologic therapy, she still prescribes a topical as "touch-up paint," to be used as needed during a flare. And flares are inevitable, so it's best to make sure a patient is prepared.
-
2 months ago | 
hcplive.com | Mona Shahriari |James Del Rosso
In the latest episode of The Medical Sisterhood, host Mona Shahriari, MD, an assistant clinical professor of dermatology at the Yale University School of Medicine and the associate director of clinical trials at Central Connecticut Dermatology Research, spoke alongside James Q.
-
Nov 18, 2024 | 
hcplive.com | Mona Shahriari |Linda Gold |Susan Taylor
In this episode of The Medical Sisterhood, host Mona Shahriari, MD, speaks with Susan Taylor, MD, and Linda Stein Gold, MD, two leaders in dermatology, about mentorship, professional growth, and the realities of balancing personal and professional responsibilities as women in medicine. Taylor, a professor and vice chair for Diversity, Equity, and Inclusion at the Perelman School of Medicine, shares how her mentor inspired her to develop the subspecialty of skin of color dermatology.
-
Oct 25, 2024 | 
dermatologytimes.com | Emma Andrus |Mona Shahriari
At this year’s Fall Clinical Dermatology Conference, Mona Shahriari, MD, FAAD, an assistant clinical professor of dermatology at Yale University and the associate director of clinical trials at Central Connecticut Dermatology Research, shared pearls for itch, psoriasis, skin of color, and the future of dermatology.
-
Oct 17, 2024 | 
hcplive.com | Mona Shahriari
00:00 - Introduction and Backgrounds 02:05 - Balancing Family and Career 04:09 - Prioritizing and Saying No 07:55 - Finding Work-Life Balance 11:18 - Building a Support Network 14:46 - The Value of Professional Friendships 16:31 - Final Thoughts and Wisdom In this episode of The Medical Sisterhood, host Mona Shahriari, MD, is joined by Alexandra Golant, MD, medical director of the Dermatology Faculty Practice and the program director of the Dermatology Residency Program at Mount Sinai, to...
-
Sep 30, 2024 | 
hcplive.com | Mona Shahriari
Introduction and Background - 00:00 Understanding Imposter Syndrome - 02:02 Personal Experiences with Imposter Syndrome - 03:29 Strategies for Overcoming Imposter Syndrome - 08:02 The Role of Support and Community - 10:34 Conclusion and Final Thoughts - 12:29 In this episode of The Medical Sisterhood, host Mona Shahriari, MD, sits down with dermatologist Tina Bhutani, MD, codirector of the Psoriasis and Skin Treatment Center and director of the Dermatology Clinical Research Unit at the...
-
Sep 25, 2024 | 
dermatologytimes.com | Maddi Hebebrand |Mona Shahriari
With September marking Hispanic Heritage month in the United States, Dermatology Times’ spoke with several leaders in the field to understand the level of diversity, research, and data associated with specific dermatological conditions within the US Hispanic population.
